Acute coronary syndrome
RecruitingStudy on Controlling Coronary Risk Factors and Platelet Aggregation Using Ramipril, Acetylsalicylic Acid, and Atorvastatin Calcium Trihydrate in Patients with Heart Disease
Study on Controlling Coronary Risk Factors and Platelet Aggregation Using Ramipril, Acetylsalicylic Acid, and Atorvastatin Calcium Trihydrate in Patients with Heart Disease
- Disease:Acute coronary syndrome
- Substances:Acetylsalicylic AcidAtorvastatin+2
Spain- Participants:18–64 years · 65+ years
- Substances:Acetylsalicylic Acid
- Sponsor:Fundacion Epic

